AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glaritus 40IU/ml Injection

Prescription Icon
Prescription Required

Marketer

Wockhardt Ltd

Salt Composition

Insulin Glargine (40IU)

Overview Glaritus 40IU/ml Injection

InsulGlo 40IU/ml Injection, a prolonged-acting insulin formulation, manages type 1 and 2 diabetes mellitus in adults and pediatric patients. Providing consistent, all-day insulin coverage, it effectively regulates blood glucose, mitigating diabetes-related complications. InsulGlo 40IU/ml Injection may be administered independently or in conjunction with rapid-acting insulin or other antidiabetic agents. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Adherence to the prescribed dosage is crucial for optimal therapeutic outcomes; discontinuation can lead to dangerously elevated blood sugar and severe consequences. This medication forms part of a comprehensive treatment plan encompassing dietary modifications, regular physical activity, and weight management as directed by your physician. Hypoglycemia (low blood sugar) is the most frequent adverse event. Precise dosing, consistent meals, and regular blood glucose monitoring are vital for its prevention; excessive alcohol consumption also increases this risk. Additional potential side effects include peripheral swelling, lipoatrophy/lipohypertrophy, hypersensitivity reactions, injection site reactions, pruritus, dermatological manifestations, and weight increase. Avoid use during hypoglycemic episodes. Prior to commencing treatment, disclose any history of renal, hepatic, or cardiovascular disease to your physician. Consult your doctor before using this medication during pregnancy or lactation.

Uses of Glaritus 40IU/ml Injection

High blood sugar condition

Major Benefits of Glaritus 40IU/ml Injection:

This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.

Common Side effects of Glaritus 40IU/ml Injection:

  • Hypoglycemia (low blood glucose level)
  • Peripheral edema
  • Lipodystrophy (skin thickening or pits at the injection site)
  • Allergic reaction
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Rash
  • Weight gain

How to use Glaritus 40IU/ml Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

How Glaritus 40IU/ml Injection works:

Glargine 40 IU/mL injection offers extended insulin action for stable, 24-hour blood glucose management. Its mechanism mimics natural insulin function, promoting glucose absorption into muscle and fat tissue while simultaneously reducing hepatic glucose output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Glaritus 40IU/ml Injection is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable medication Glaritus, at a concentration of 40 IU/ml, is typically deemed safe for use throughout gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Glaritus 40 IU/ml Injection safely. Available human data indicates minimal infant risk associated with this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glaritus 40 IU/ml Injection cautiously, as dose modification may be necessary. Blood glucose levels should be regularly monitored to guide dosage adjustments. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Glaritus 40IU/ml Injection. Dosage modification of Glaritus 40IU/ml Injection might be necessary. Physician consultation is advised. Routine glucose level checks are suggested to guide dosage adjustments.

What if you forget to take Glaritus 40IU/ml Injection :

For a missed Glaritus 40IU/ml Injection, administer the dose immediately if feasible. If your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glaritus 40IU/ml Injection

LabelValue
Chemical Type Modified insulin
Developing Habits No.
Treatment Category Diabetes medication
Active Class Long-acting insulin analogs

FAQs on Glaritus 40IU/ml Injection

Glargine insulin (40 IU/ml) is a synthetic insulin analog closely resembling human insulin. Providing a prolonged, consistent reduction in blood glucose, its once-daily administration effectively manages type 1 and type 2 diabetes in adults and children.
Glaritus 40IU/ml Injection is administered subcutaneously. Your doctor will demonstrate the proper injection technique and suitable injection sites (abdomen, thighs, arms, hips, or buttocks). Rotate injection sites within the chosen area for each dose; for example, vary the injection point on your abdomen by about 1cm each day. Alternating injection sides (e.g., right then left) is also helpful. This rotation minimizes complications like lipodystrophy (fat tissue thickening), irritation, and pain from repeated injections at the same site. After 1-2 weeks, shift to a different body area as directed by your doctor. Contact your doctor if you experience any difficulties.
Glaritus 40IU/ml Injection, a long-acting medication, is typically administered once daily. While the time of day is flexible, consistent daily timing is recommended.
Taking more Glaritus 40IU/ml Injection than prescribed can cause dangerously low blood sugar (hypoglycemia). This may range from mild (anxiety, sweating, weakness, tremors, rapid heartbeat) to severe (seizures, unconsciousness). Monitor your blood sugar closely for 24 hours. Treat mild hypoglycemia with sugary foods like candy or juice. Severe hypoglycemia is a medical emergency requiring immediate medical attention. Consult your doctor regardless of severity.
Keep Glaritus 40IU/ml Injection out of children's reach, stored in its original container. Unopened vials and pens should be refrigerated, but not frozen. Refrigerate unopened injections until the expiration date on the label. Never use frozen or thawed Glaritus 40IU/ml Injection. If refrigeration isn't possible, store unopened vials at room temperature, protected from direct sunlight and excessive heat. The solution should be clear, colorless, and particle-free.
Discuss insulin dose adjustments with your doctor. Illness requires closer blood sugar monitoring. Inform your doctor of all medications you take, as they can impact insulin effectiveness and necessitate dose changes. Dietary changes, such as missed meals or altered food intake, also affect insulin needs. Exercise, alcohol, and stress can influence blood sugar levels. Pregnant or breastfeeding women should consult their doctor before using Glaritus 40IU/ml Injection, as dosage adjustments may be necessary.
Glaritus 40IU/ml Injection rarely causes serious side effects, though severe allergic reactions (rash, hives, itching, wheezing, rapid heart rate, low blood pressure) are possible; seek immediate medical attention if these occur. Other potential side effects include severe hypoglycemia (dizziness, sweating, anxiety, confusion, headache, blurred vision, slurred speech, shakiness, rapid heartbeat, seizures, unconsciousness). Concurrent use of TZDs may increase the risk of heart failure, even in individuals with no prior history. Weight gain and ankle/foot swelling may also occur. Report any of these side effects to your doctor promptly.
Glaritus 40IU/ml Injectio...
1,037
MRP 1,143
9% off